Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies

被引：28

作者：

Martin-Santos, Cecilia ^{[1
]}

Michelucci, Elena ^{[2
]}

Marzo, Tiziano ^{[3
]}

Messori, Luigi ^{[3
]}

Szumlas, Piotr ^{[4
]}

Bednarski, Patrick J. ^{[4
]}

Mas-Balleste, Ruben ^{[1
]}

Navarro-Ranninger, Carmen ^{[1
]}

Cabrera, Silvia ^{[1
]}

Aleman, Jose ^{[5
]}

机构：

[1] Univ Autonoma Madrid, Fac Ciencias, Dept Quim Inorgan Modulo 7, E-28049 Madrid, Spain

[2] Univ Florence, Mass Spectrometry Ctr CISM, I-50019 Florence, Italy

[3] Univ Florence, Dept Chem Ugo Schiff, Lab Met Med MET MED, I-50019 Florence, Italy

[4] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Pharmazeut Med Chem, D-17487 Greifswald, Germany

[5] Univ Autonoma Madrid, Fac Ciencias, Dept Quim Organ Modulo 1, E-28049 Madrid, Spain

来源：

JOURNAL OF INORGANIC BIOCHEMISTRY | 2015年 / 153卷

关键词：

Gold(III) complexes; Quinoline derivatives; Cytochrome c interaction; SULFONAMIDE PLATINUM COMPLEXES; ALZHEIMERS-DISEASE; SOLUTION CHEMISTRY; ANTITUMOR AGENTS; CLIOQUINOL; PROTEASOME; TARGETS; DERIVATIVES; DESIGN; COPPER;

D O I：

10.1016/j.jinorgbio.2015.09.012

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this article, we report on the synthesis and the chemical and biological characterization of novel gold(III) complexes based on hydroxyl- or amino-quinoline ligands that are evaluated as prospective anticancer agents. To gain further insight into their reactivity and possible mode of action, their interactions with model proteins and standard nucleic acid molecules were investigated. (C) 2015 Elsevier Inc All rights reserved.

引用

页码：339 / 345

页数：7

共 46 条

[1] Novel N-sulfonamide trans-platinum complexes: synthesis, reactivity and in vitro evaluation
Aleman, Jose
del Solar, Virginia
Alvarez-Valdes, Amparo
Rios-Luci, Carla
Padron, Jose M.
Navarro-Ranninger, Carmen
[J]. MEDCHEMCOMM, 2011, 2 (08) : 789 - 793
[2] [Anonymous], 2001, SHELXTL NT VERS 6 12
[3] [Anonymous], 2004, SAINT V7 12A AR DET
[4] Barnham K. J., 2004, 8-hydroxy quinoline derivatives, Patent No. [WO 2004/007461, 2004007461]
[5] Gold compounds as therapeutic agents for human diseases
Berners-Price, Susan J.
Filipovska, Aleksandra
[J]. METALLOMICS, 2011, 3 (09) : 863 - 873
[6] A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
Bertrand, Benoit
Casini, Angela
[J]. DALTON TRANSACTIONS, 2014, 43 (11) : 4209 - 4219
[7] Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines:: comparisons with the National Cancer Institute data
Bracht, K
Boubakari
Grünert, R
Bednarski, PJ
[J]. ANTI-CANCER DRUGS, 2006, 17 (01) : 41 - 51
[8] Therapeutics for Alzheimer's disease based on the Metal Hypothesis
Bush, Ashley I.
Tanzi, Rudolph E.
[J]. NEUROTHERAPEUTICS, 2008, 5 (03) : 421 - 432
[9] Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: New insights from X-ray diffraction and mass spectrometry studies
Casini, Angela
Guerri, Annalisa
Gabbiani, Chiara
Messori, Luigi
[J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2008, 102 (5-6) : 995 - 1006
[10] Gold(III) compounds as anticancer agents: Relevance of gold-protein interactions for their mechanism of action
Casini, Angela
Hartinger, Christian
Gabbiani, Chiara
Mini, Enrico
Dyson, Paul J.
Keppler, Bernard K.
Messori, Luigi
[J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2008, 102 (03) : 564 - 575

← 1 2 3 4 5 →